
Tong Sun MD, PhD
@suntong100
Yale Pathology
ID: 172426605
29-07-2010 17:52:49
55 Tweet
138 Followers
95 Following

According to this 2016 study by Chris VandenBussche et al, morphologists tended to overestimate the N:C ratio, particularly at ratios close to #ParisSystem recommended cutoff values. Revisit this top-cited paper: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…


KRAS mutation analysis is still a cost-effective ancillary testing for indeterminate biliary cytology specimens. Cancer Cytopathology Yale Pathology doi.org/10.1002/cncy.2…


SMARCA4-deficient NSCLCs can have a wide spectrum of cytomorphologic features, ranging from a relatively well differentiated adenocarcinoma to a poorly differentiated/undifferentiated carcinoma acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Tong Sun MD, PhD @yalepathres #CytoPath


Tied with 5th place in our top-scoring Q2 2022 Altmetric output countdown is the article by Tong Sun MD, PhD Guoping Cai, MD et al that discusses KRAS mutation biliary brushing cytology. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…


Results demonstrated that KRAS mutation identified in bile duct brushing specimens is more likely assoc. w/ malignant bile duct strictures, suggesting an ancillary role of KRAS mutation analysis in triaging indeterminate cytology diagnoses acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Tong Sun MD, PhD


Read our August issue! 📘 ow.ly/4cZg50KaBP0 In this issue: ➡️ . et al on recruiting the future of pathology ➡️ Huiying Wang et al on the non-dx category of the pediatric #MilanSystem ➡️ Tong Sun MD, PhD et al on the cytomorphology of SMARCA4- dNSCLC


Results demonstrated that KRAS mutation identified in bile duct brushing specimens is more likely assoc w. malignant bile duct strictures, suggesting an ancillary role of KRAS mutation analysis in triaging indeterminate cytology dxs acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Tong Sun MD, PhD Guoping Cai, MD



From Tong Sun MD, PhD et al: Findings suggest the necessity for each laboratory to perform its own ROM analysis based on its statistics for ISRSFC-tiered classification terminology acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #CytoPath


How up-to-date are you on current recs for #LungCancer biomarker testing? This article by Paul VanderLaan Sinchita Roy MD PhD outlines 7 targets (EGFR, ALK, ROS1, BRAF, MET exon 14, RET, & PD-L1) that need testing in #NSCLC. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #CytoChat


Join Pei Hui & others for the 1st International Society of Gynecologic Pathologists diagnostic update course in Mandarin on March 4-5. This course, by Zoom livestream, features international #pathology & #obgyn experts, including Tong Sun MD, PhD of Yale Pathology, & panel discussions in Mandarin. bit.ly/3ZHGlrN





Remember to register now for the 2nd Annual Diagnostic #Pathology Review, on Nov. 4-5 at The Yale Club of NYC. It features the world-class Pathology faculty of Yale School of Medicine, including Pei Hui, Natalia Buza & Tong Sun MD, PhD. Follow link for registration information. bit.ly/45ohT13


We had an enlightening time at our 2nd Diagnostic #Pathology Annual CME Review at the The Yale Club of NYC, Nov. 4-5, exploring #genitourinary & #gynecology pathology subspecialties. Thanks to everyone who attended & to our esteemed Yale School of Medicine faculty who presented. Looking forward to 2024



Yale Pathology Labs teams with Yale ENT to provide free head & neck #cancer screenings at annual Beverly Levy Walk & Block Party in Orange that raises funds for #gynecologic cancer research. Yale School of Medicine Yale Cancer Center Angelique W. Levi, M.D. Tong Sun MD, PhD Stephanie Weirsman bit.ly/43qRDDB
